Proconvulsant effects induced by pyridoxine in young rats

Related Experiment Video

Updated: Oct 30, 2026

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

S Veresová1, R Kábová, L Velísek

  • 1Department of Pathological Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.

Epilepsy Research
|April 29, 1998
PubMed

Insights

High doses of vitamin B6 can cause neurotoxicity. In young rats, pyridoxine (vitamin B6) induced abnormal brain activity, suggesting potential proconvulsant effects in pediatric neurology.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pediatric Neurology

Background:

  • High doses of pyridoxine (vitamin B6) are known to be neurotoxic in adult populations.
  • Understanding the neurotoxic potential of vitamin B6 in developing nervous systems is crucial.

Purpose of the Study:

  • To investigate the effects of varying doses of intraperitoneally administered pyridoxine (vitamin B6) on different age groups of rats.
  • To determine the age-dependent neurotoxic and proconvulsant effects of vitamin B6.

Main Methods:

  • Pyridoxine (vitamin B6) was administered intraperitoneally to rats at doses of 100, 250, and 400 mg/kg.
  • Electroencephalogram (EEG) and motor activity were monitored in rats aged 7, 12, 18, and 60 days.

Main Results:

  • Pyridoxine (vitamin B6) administration induced epileptiform EEG discharges across all studied age groups, irrespective of motor activity.
  • Motor seizures were infrequent and primarily observed in 18-day-old rats receiving a 250 mg/kg dose of pyridoxine (vitamin B6).

Conclusions:

  • The findings suggest that young rats exhibit altered responses to high-dose pyridoxine (vitamin B6) compared to adults.
  • Pyridoxine (vitamin B6) may possess proconvulsant properties in young rats at doses relevant to pediatric neurological applications.

More Related Videos

Seizure Activity Induced by Electroshock in Drosophila Larvae06:10

Seizure Activity Induced by Electroshock in Drosophila Larvae

Published on: June 6, 2025

Pentylenetetrazole-Induced Kindling Mouse Model07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...